$MRVL

Durn Daniel sold $632K of MRVL

Durn Daniel (Chief Financial Officer) sold 2,250 shares of Marvell Technology, Inc. (MRVL) at $281.01 ($0.63M total) on 2026-06-23.

Original reporting
SEC EDGAR · Durn Daniel
Published Jun 23, 2026, 8:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRVL
Neutral
low confidence
Mentioned
$MRVL
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (shares, price, total value) filed on 2026-06-23; there is no accompanying operational or financial update.

02

Market read

Traders may monitor insider activity as a sentiment input, but this filing alone is unlikely to drive a sustained repricing without additional company catalysts.

03

What to watch

The filing doesn’t disclose motivations, and the post-sale holdings (6,902 shares) suggest the sale may not materially change control or long-term exposure.

Relevance 5/10Novelty 3/10Timing: Filed 2026-06-23 (after-hours) for an insider sale executed the same day.

Background

This is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc. (MRVL).

Company-level read

Ticker impact

$MRVLNeutralLow confidence
Context

Marvell CFO Durn Daniel filed a Form 4 showing an open-market sale of 2,250 shares at $281.01 on 2026-06-23.

Expected impact

Likely limited near-term impact; any effect would be incremental sentiment rather than a directional driver.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the filing provides a fresh datapoint but no accompanying company-specific news (guidance, contracts, litigation, etc.).

Market effects

Minimal; this is company-specific insider activity with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan doesn’t necessarily imply bearish information; CFO sales can be driven by diversification, taxes, or pre-scheduled personal liquidity needs.

Key entities

  • Marvell Technology, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Durn Daniel

    Marvell CFO who sold 2,250 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.